Glimfirst-MP 2 Tablet SR
Marketer
Zyphar's Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimfirst-MP 2 Tablet SR
Duo-Glycemic SR tablets combine medications to effectively manage blood glucose. This dual-action formulation, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It optimizes insulin utilization, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and regimen. Taking this medication with food minimizes gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. An overdose can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Commonly reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must seek medical counsel before use. Renal function tests will be performed before treatment initiation. Limit alcohol consumption, as it may amplify the risk of adverse effects.
Uses of Glimfirst-MP 2 Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glimfirst-MP 2 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Glimfirst-MP 2 Tablet SR with a meal.
Common Side effects of Glimfirst-MP 2 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimfirst-MP 2 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimfirst-MP 2 Tablet SR should be administered with a meal.
How Glimfirst-MP 2 Tablet SR works:
Glimfirst-MP 2 Tablet SR combines three distinct antidiabetic agents—glimepiride, metformin, and pioglitazone—to optimize blood glucose management when monotherapy or dual-drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimfirst-MP 2 Tablet SR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimfirst-MP 2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimfirst-MP 2 tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk with possible infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when administering Glimfirst-MP 2 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised. Glimfirst-MP 2 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Glimfirst-MP 2 Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimfirst-MP 2 Tablet SR is contraindicated in individuals with severe liver dysfunction.
What if you forget to take Glimfirst-MP 2 Tablet SR :
Should you forget to take a Glimfirst-MP 2 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimfirst-MP 2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


